AXTA vs EMN
Axalta vs Eastman Chemical Company — AI-powered side-by-side comparison
VS
EMN
Eastman Chemical Company
66
Buy
| Metric | AXTA | EMN |
|---|
| AI Score |
63
|
66
|
| Price |
$38.18
|
$73.65
|
| P/E Ratio |
23.43×
|
19.03×
|
| ROE |
16.1%
|
8.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
32.6%
|
19.9%
|
| Debt / Equity |
1.22×
|
0.86×
|
| Dividend Yield |
0.0%
|
4.5%
|
| RSI (14) |
75.7
|
74.0
|
| Beta |
1.239
|
1.083
|
| Expected Upside |
+0.4%
|
+5.5%
|
AI Committee View
Current Innellis committee reasoning for AXTA versus EMN.
EMN leads by 3 points.
EMN scores 66/100 (Buy) versus AXTA at 63/100 (Buy).
AXTA Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — bollinger bandwidth of 26.7% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- RSI at 76 is in overbought territory — Technical
- Bollinger bandwidth of 26.7% signals elevated volatility — Risk
EMN Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- RSI at 74 is in overbought territory — Technical